Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2012Circulation Heart FailureOpen Access

Still at the Drawing Board

View Full Paper
Ask AI
Bookmark
Share

Key result

HFpEF accounts for ~90% of HF in US women, underscoring the need for novel therapies.

Population

Patients with heart failure with preserved ejection fraction or mildly reduced left ventricular dysfunction…

Design

Editorial

Authors

ELEldrin F. LewisGeneral Cardiology

Discussion

Loading...

Member takes

Implication

HFpEF predominates among women with HF; leaves open whether sex-specific trials will identify effective therapies.

Structured PICO

P
Population
Patients with heart failure with preserved ejection fraction (HF-PEF) or mildly reduced left ventricular dysfunction in the United States

Highlights the critical need for novel therapies and randomized clinical trials in patients with HF-PEF to improve mortality, hospitalizations, and quality of life.

Cite This Study

Eldrin F. Lewis (2012) conducted an editorial in Heart failure with preserved ejection fraction (HF-PEF). Heart failure with preserved ejection fraction accounts for approximately 90% of women and 70% of men among 5.7 million US heart failure patients, highlighting the need for novel therapies.

synapsesocial.com/papers/6aa5f29dc616a76b5feed17bhttps://doi.org/10.1161/circheartfailure.112.966861

Topics

HFrEF treatmentHeart failureHFpEF managementWomen and heart disease
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patient Perception of the Effect of Treatment with Candesartan in Heart Failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme2005 · 27 citations
  2. 2Measuring Health-Related Quality of Life1993 · 4,002 citations
  3. 3Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM2006 · 250 citations
  4. 4Assessment of Long-Term Effects of Irbesartan on Heart Failure With Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial2012 · 78 citations
  5. 5Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction2008 · 1,967 citations